Clinical Significance of Hyperbilirubinemia Among HIV-1–Infected Patients Treated with Atazanavir/Ritonavir Through 96 Weeks in the CASTLE Study

CASTLE was a randomized 96-week study that demonstrated that atazanavir/ritonavir (ATV/r) was noninferior to lopinavir/ritonavir (LPV/r) in treatment-naïve HIV-infected patients. Analyses were carried out among patients who received ATV/r in the CASTLE study to better understand the clinical signifi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: McDonald, Cheryl, Uy, Jonathan, Hu, Wenhua, Wirtz, Victoria, Juethner, Salome, Butcher, David, McGrath, Donnie, Farajallah, Awny, Moyle, Graeme
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2012
Teme:
Clinical and Epidemiologic Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3335103/
https://ncbi.nlm.nih.gov/pubmed/22404426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/apc.2011.0092
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items